Development and Theoretical Underpinnings of the PRIORITY Intervention: A Parenting Intervention to Prevent

Nicola R O'Donnell1, Rose-Marie Satherley1, Mary John1,2

  • 1School of Psychology, University of Surrey, Guildford, United Kingdom.

Insights

Children and young people with type 1 diabetes are at high risk for disordered eating. A new psychological intervention for parents aims to prevent this, improving health outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Psychology
  • Behavioral Medicine

Background:

  • Children and young people (CYP) with type 1 diabetes (T1D) have double the risk of developing disordered eating (T1DE) and eating disorders.
  • T1DE in T1D is linked to severe health risks, including diabetic ketoacidosis and elevated HbA1c levels.
  • Limited psychological support exists for CYP with T1D and their families, despite evidence for preventative psychological interventions.

Purpose of the Study:

  • To describe the development and theoretical basis of a preventative psychological intervention for parents of CYP aged 11-14 with T1D.
  • To address the gap in psychological support for T1D and T1DE prevention.
  • To inform future integration into routine NHS diabetes care.

Main Methods:

  • Intervention development informed by the Information Motivation Behaviour Skills model and Behaviour Change Technique Taxonomy.
  • Co-development with an expert advisory group including clinicians and families affected by T1D.
  • Manualized intervention comprising two online group workshops and supplementary online materials.

Main Results:

  • The intervention is manualized and includes online group workshops and materials.
  • Feasibility findings are pending and will guide alignment with routine care.
  • The intervention is designed for parents of 11-14 year olds with T1D.

Conclusions:

  • Early detection and intervention are critical for preventing T1DE in CYP with T1D.
  • This psychological intervention for parents offers a potential strategy to improve well-being.
  • Further research and feasibility findings will refine the intervention for clinical practice.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
322
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
150
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
220